These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19411616)

  • 1. Identification of a novel beta-cell glucokinase (GCK) promoter mutation (-71G>C) that modulates GCK gene expression through loss of allele-specific Sp1 binding causing mild fasting hyperglycemia in humans.
    Gasperíková D; Tribble ND; Staník J; Hucková M; Misovicová N; van de Bunt M; Valentínová L; Barrow BA; Barák L; Dobránsky R; Bereczková E; Michálek J; Wicks K; Colclough K; Knight JC; Ellard S; Klimes I; Gloyn AL
    Diabetes; 2009 Aug; 58(8):1929-35. PubMed ID: 19411616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucokinase gene mutations (MODY 2) in Asian Indians.
    Kanthimathi S; Jahnavi S; Balamurugan K; Ranjani H; Sonya J; Goswami S; Chowdhury S; Mohan V; Radha V
    Diabetes Technol Ther; 2014 Mar; 16(3):180-5. PubMed ID: 24405491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation.
    Chakera AJ; Steele AM; Gloyn AL; Shepherd MH; Shields B; Ellard S; Hattersley AT
    Diabetes Care; 2015 Jul; 38(7):1383-92. PubMed ID: 26106223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild fasting hyperglycemia in children: high rate of glucokinase mutations and some risk of developing type 1 diabetes mellitus.
    Codner E; Rocha A; Deng L; Martínez-Aguayo A; Godoy C; Mericq V; Chung WK
    Pediatr Diabetes; 2009 Sep; 10(6):382-8. PubMed ID: 19309449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
    Gloyn AL
    Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of the glucokinase impaired function - GCK MODY today.
    Hulín J; Škopková M; Valkovičová T; Mikulajová S; Rosoľanková M; Papcun P; Gašperíková D; Staník J
    Physiol Res; 2020 Dec; 69(6):995-1011. PubMed ID: 33129248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
    Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
    Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Sp1 and SREBP-1a in the insulin-mediated regulation of glucokinase transcription in the liver of gilthead sea bream (Sparus aurata).
    Egea M; Metón I; Córdoba M; Fernández F; Baanante IV
    Gen Comp Endocrinol; 2008 Jan; 155(2):359-67. PubMed ID: 17686483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY).
    Li X; Ting TH; Sheng H; Liang CL; Shao Y; Jiang M; Xu A; Lin Y; Liu L
    BMC Pediatr; 2018 Mar; 18(1):101. PubMed ID: 29510678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sp1 and Sp3 regulate glucokinase gene transcription in the liver of gilthead sea bream (Sparus aurata).
    Egea M; Metón I; Baanante IV
    J Mol Endocrinol; 2007 Apr; 38(4):481-92. PubMed ID: 17446237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.
    Gloyn AL; Odili S; Zelent D; Buettger C; Castleden HA; Steele AM; Stride A; Shiota C; Magnuson MA; Lorini R; d'Annunzio G; Stanley CA; Kwagh J; van Schaftingen E; Veiga-da-Cunha M; Barbetti F; Dunten P; Han Y; Grimsby J; Taub R; Ellard S; Hattersley AT; Matschinsky FM
    J Biol Chem; 2005 Apr; 280(14):14105-13. PubMed ID: 15677479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic deletion of a short fragment of glucokinase in rabbit by CRISPR/Cas9 leading to hyperglycemia and other typical features seen in MODY-2.
    Song Y; Sui T; Zhang Y; Wang Y; Chen M; Deng J; Chai Z; Lai L; Li Z
    Cell Mol Life Sci; 2020 Aug; 77(16):3265-3277. PubMed ID: 31720743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.
    Osbak KK; Colclough K; Saint-Martin C; Beer NL; Bellanné-Chantelot C; Ellard S; Gloyn AL
    Hum Mutat; 2009 Nov; 30(11):1512-26. PubMed ID: 19790256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia.
    Valentínová L; Beer NL; Staník J; Tribble ND; van de Bunt M; Hučková M; Barrett A; Klimeš I; Gašperíková D; Gloyn AL
    PLoS One; 2012; 7(4):e34541. PubMed ID: 22493702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperglycemia caused by mutation of GCK gene in 10 patients analysis of clinical and mutation characteristics].
    Zhang J; Yuan K; Ding SX; Kong YM; Zhu JF; Fang YL; Liang L; Fu JF; Wang CL
    Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):440-444. PubMed ID: 31216801
    [No Abstract]   [Full Text] [Related]  

  • 16. Caudal regression syndrome in a fetus of a glucokinase-maturity-onset diabetes of the young pregnancy.
    Taylor RAM; Mackie A; Mogra R; Pinner J; Rajendran S; Ross GP
    Diabet Med; 2019 Feb; 36(2):252-255. PubMed ID: 30362177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naturally occurring glucokinase mutations are associated with defects in posttranslational S-nitrosylation.
    Ding SY; Tribble ND; Kraft CA; Markwardt M; Gloyn AL; Rizzo MA
    Mol Endocrinol; 2010 Jan; 24(1):171-7. PubMed ID: 19934346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glucokinase mutation p.T206P is common among MODY patients of Jewish Ashkenazi descent.
    Gozlan Y; Tenenbaum A; Shalitin S; Lebenthal Y; Oron T; Cohen O; Phillip M; Gat-Yablonski G
    Pediatr Diabetes; 2012 Sep; 13(6):e14-21. PubMed ID: 21978167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Changes in the Glucokinase Gene (GCK) Associated with the Diagnosis of Maturity Onset Diabetes of the Young (MODY) in Pregnant Women and Newborns.
    Lepore C; Damaso E; Suazo V; Queiroz R; Junior RL; Moisés E
    Curr Diabetes Rev; 2022; 18(6):e060821195358. PubMed ID: 34365926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies.
    Steele AM; Wensley KJ; Ellard S; Murphy R; Shepherd M; Colclough K; Hattersley AT; Shields BM
    PLoS One; 2013; 8(6):e65326. PubMed ID: 23799006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.